经皮经肝内镜钬激光碎石术治疗胆管结石的安全性、疗效与可行性
本回顾性研究纳入2019年1月至2021年12月单中心530例肝内和/或胆总管结石患者,评估经皮经肝内镜钬激光碎石术(PTEHL)的安全性与疗效。技术成功率为98.7%(523/530),并发症发生率14.2%,其中严重并发症4.7%、轻微并发症9.4%。作者认为PTEHL对肝内外胆管结石安全有效,尤其适用于复杂结石或ERCP失败者。
要点
- PTEHL技术成功率达98.7%,仅7例因目标结石未取出需手术。
- 并发症发生率14.2%,其中严重并发症4.7%、轻微并发症9.4%。
- 92.1%患者单次PTEHL即可完成,适用于复杂结石或ERCP失败者。
核心结论
- PTEHL是治疗肝内和肝外胆管结石的安全有效方法,对复杂结石尤其当ERCP不成功或遇到重大困难时是有价值的选择。
研究设计与样本
- 单中心回顾性研究,纳入2019年1月至2021年12月530例肝内和/或胆总管结石患者(平均年龄55.6±8.5岁,64.2%女性),以术后胆管造影确认结石清除,并发症按介入放射学会不良事件分类记录。
诊断标准与关键数值
- 技术成功定义为目标结石被取出,成功523例(98.7%);平均结石大小20.9±11.9 mm,多发结石460例(86.8%);肝内外胆管均有结石225例(42.5%);胆肠吻合50例(9.4%);ERCP取石失败18例(3.4%);术前胆道引流271例(51.1%);单次PTEHL 488例(92.1%);并发症75例(14.2%),严重并发症4.7%,轻微并发症9.4%。
临床应用与阅片要点
- 对于大或复杂结石、或ERCP失败或存在困难的肝内外胆管结石患者,PTEHL可作为治疗选择;有胆管炎征象者需先行PTEHL前引流。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate the safety and efficacy of percutaneous transhepatic endoscopic holmium laser lithotripsy (PTEHL) for patients with intrahepatic bile duct (IHBD) and common bile duct (CBD) stones.
MATERIAL AND METHODS: This retrospective study included 530 patients (mean age: 55.6 ± 8.5; 64.2% female) with IHBD and/or CBD stones at a single institution from January 2019 to December 2021. PTEHL was the chosen treatment for patients with large, complex stones, or those for whom Endoscopic Retrograde Cholangiopancreatography (ERCP) failed or presented difficulties. Patients showing signs of cholangitis required pre-PTEHL drainage. Stone clearance was confirmed by post-procedural cholangiography, and the technique was deemed successful when target stones were removed. Complications were recorded according to the Society of Interventional Radiology adverse event classification.
RESULTS: The mean stone size was 20.9 ± 11.9 mm, multiple stones observed in 460 patients (86.8%). A total of 225 patients (42.5%) had stones in both the IHBD and CBD; biliary-enteric anastomosis in 50 patients (9.4%). ERCP for stone removal proved unsuccessful in 18 patients (3.4%). Pre-IHBD drainage was performed in 271 patients (51.1%). The majority (488 patients, 92.1%) underwent a single PTEHL session. The technique was successful in 523 patients (98.7%), with 7 patients requiring surgery due to unsuccessful target stone removal. Complications were noted in 75 patients (14.2%), including 4.7% with severe complications and 9.4% with minor complications.
CONCLUSION: PTEHL is a safe and effective method for the treatment of both intrahepatic and extrahepatic bile duct stones. This approach is a valuable option for complex stone cases, particularly when ERCP is unsuccessful or encounters significant challenges.
CLINICAL RELEVANCE STATEMENT: Percutaneous Transhepatic Endoscopic Holmium Laser Lithotripsy is a safe and effective treatment method for intrahepatic and extrahepatic biliary stones, particularly in cases of complex stones.
KEY POINTS: Percutaneous transhepatic biliary stone removal is difficult for large or intraductal stones. Percutaneous Transhepatic Endoscopic Holmium Laser Lithotripsy (PTEHL) demonstrated a high success rate with few major complications. PTEHL can treat biliary stones, particularly stones that are difficult or have failed ERCP treatment.
引用
- Thai Binh N, Son Nam P, Quoc Hoa T, et al. Safety, efficacy, and feasibility of percutaneous transhepatic endoscopic holmium laser lithotripsy for bile duct stones. Eur Radiol. 2024. PMID: 38789793. doi:10.1007/s00330-024-10811-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。